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secutive tests, the mean geometrical accuracy was 0.48 
 8 0.23 mm. Besides QA phantoms and analysis software 
developed in-house, the use of commercially available 
tools facilitated the QA according to the DIN 6875-1 with 
which our results complied. 
 Copyright © 2004 S. Karger AG, Basel 
 Introduction 
 Intracranial stereotactic radiosurgery (SRS) and ste-
reotactic radiotherapy (SRT) represent a noninvasive, 
single (SRT) or fractionated (SRS) irradiation method for 
lesions within the skull, relying on the accurate localiza-
tion of anatomical structures, small radiation fi elds (di-
ameters down to 4 mm) and steep dose gradients (up to 
40% per mm). To date, more than 230,000 patients, suf-
fering from meningiomas, cerebellopontine angle 
schwannomas, arteriovenous malformations, pituitary 
adenomas, brain metastases, glial tumours or trigeminal 
neuralgia have been treated by 179 Gamma Knife ®  cen-
tres worldwide. Quality assurance (QA) in SRS and SRT 
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 Abstract 
 The new DIN (‘Deutsche Industrie-Norm’) 6875-1, which 
is currently being fi nalised, deals with quality assurance 
(QA) criteria and tests methods for linear accelerator and 
Gamma Knife stereotactic radiosurgery/radiotherapy in-
cluding treatment planning, stereotactic frame and ste-
reotactic imaging and a system test to check the whole 
chain of uncertainties. Our existing QA program, based 
on dedicated phantoms and test procedures, has been 
refi ned to fulfi ll the demands of this new DIN. The radio-
logical and mechanical isocentre corresponded within 
0.2 mm and the measured 50% isodose lines were in 
agreement with the calculated ones within less than
0.5 mm. The measured absorbed dose was within 3%. 
The resultant output factors measured for the 14-, 8- and 
4-mm collimator helmet were 0.9870  8 0.0086, 0.9578 
 8 0.0057 and 0.8741  8 0.0202, respectively. For 170 con-
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is of utmost importance and one of the tasks of medical 
physicists in charge of a clinical SRS/SRT program. In 
the literature, quite a number of contributions addressing 
this issue can be found  [1–15] . Recently, the draft of the 
new E-DIN (‘Deutsche Industrie-Norm’ valid in Europe) 
6875-1 has been published  [16] and is currently being fi -
nalised. This fi rst part of the DIN deals with acceptance 
procedures and will be the basis for the second part de-
scribing regular constancy checks. Our aim was to adapt 
the existing QA program for the Gamma Knife to the new 
standard, estimate on the expenditure necessary and to 
give notice of this new standard. 
 Materials and Methods 
 DIN 6875-1 – Introduction 
 This DIN covers functional performance characteristics for ste-
reotactically guided, percutaneous photon irradiations in the head 
and neck which are characterized by a high geometrical accuracy 
of the irradiation (0.5–2.0 mm) and a steep dose gradient. Test 
conditions and test procedures are defi ned including the irradiation 
device (adapted linear electron accelerator with fi xed tertiary or 
micro-multileaf collimator and Gamma Knife), the treatment plan-
ning system, the stereotactic instrument and diagnostic imaging 
modalities [CT, MRI, angiography, digital subtraction angiography 
(DSA)]. 
 The small dimensions of the therapeutically used irradiation 
fi elds require dedicated dosimetrical test procedures. An essential 
aim of this standard is the comparability of functional performance 
characteristics for different irradiation devices of different manu-
facturers. Additionally, test procedures and test conditions for the 
system test  [1] , simulating the complete treatment chain, are de-
scribed. 
 The aim of this standard is also to describe acceptance and 
regular constancy tests of an SRS/SRT system. 
 DIN 6875-1 – Demands 
 Dosimeter. In addition to standard requirements, the geometri-
cal resolution must be small compared to the radiation fi elds. In 
general, it is recommended to perform comparative measurements 
using different dosimeters such as radiochromic fi lms, diamond 
detectors, thermoluminescence dosimeters and alanine pellets. 
 Irradiation. Irradiations in order to measure the dose distribu-
tion have to be performed in the same way as for patients including 
diagnostic imaging modalities (CT, MRI, angiography, DSA). 
 Phantom. A homogeneous, regular phantom (sphere) which al-
lows the position of dosimeters in the central part must be used. 
 DIN 6875-1 – Dosimetric Functional Performance 
Characteristics for Gamma Knife 
 There are four collimator helmets (4, 8, 14 and 18 mm); these 
are geometrical projections of the collimator aperture at the unit 
centre point of the Gamma Knife. The superposition of all 201 
beams then produces approximately spherically shaped dose distri-
butions, with full width at half maximum dimensions (in x and y 
directions) of 6, 11, 19 and 24 mm, respectively, at the isocen-
tre  [2] . 
 Output Factor. The output factor has to be determined for the 
4-, 8- and 14-mm collimator helmet relative to the 18-mm colliP-
mator helmet, which produces the largest fi eld size using a spherical 
phantom  [3, 4] . 
 Dose Distribution. For all collimator helmets, the isodose curves 
in three orthogonal planes, determined by the stereotactic coordi-
nate system and their deviation to the calculated ones, have to be 
documented. 
 DIN 6875-1 – Dosimetric Functional Performance 
Characteristics for Linear Accelerator 
 Output Factor. The output factor has to be determined on the 
central axis at the reference depth relative to the calibration condi-
tion for the dose monitor. Output factors have to be determined for 
all fi xed tertiary collimators and for the minimal and maximal, as 
well as for a medium, rectangular fi eld size for micro-multileaf col-
limators  [5] . 
 Tissue-Phantom Ratio. The tissue-phantom ratios for the same 
set-up as for the output factor measurements have to be measured 
on the central axis. For multileaf collimators, spot checks have to 
be performed for any fi eld shape in order to compare the measured 
depth dose to the calculated one. 
 Dose Profi les. Normalised dose profi les with a suffi cient geo-
metrical resolution have to be documented for the same set-up as 
for output factor measurements at isocentre position. 
 DIN 6875-1 – Geometrical Functional Performance 
Characteristics 
 Stereotactic Localisation. The relationship between image coor-
dinates and stereotactic coordinates has to be derived with the help 
of fi ducial systems. If non-linear image distortions apply, they have 
to be determined with dedicated phantoms and the patient images 
have to be corrected. 
 Target Points/Volumes in Stereotactic Space. Target coordi-
nates are given in the stereotactic space and usually show some 
uncertainties due to the imaging (distortions, artefacts), stereotactic 
frame deformations/instabilities, fi ducial determination and coor-
dinate transformation. These geometrical uncertainties have to be 
estimated by using known target points in the stereotactic space 
and have to be determined in the same way as target coordinates 
for patients. 
 DIN 6875-1 – Device Functional Performance Characteristics 
for Linear Accelerator 
 Ideally gantry and patient table rotation axis should intersect in 
a single point. The following functional performance characteristics 
are specifi c for the given device and have to be determined  [6] . 
 (1) Distance (in millimetres) of gantry rotation axis and isocen-
tric patient table rotation axis (geometric isocentre). 
 (2) Radius (in millimetres) of the isocentre sphere, which is the 
smallest sphere through which the central ray of the radiation beam 
runs for all gantry and table rotation angles (Winston-Lutz test, ra-
diation isocentre). 
 (3) The deviation of the geometrical and radiation isocentre 
from the optical indication of the isocentre must be specifi ed (in 
millimetres) in three orthogonal planes within the room coordinate 
system. 
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 DIN 6875-1 – Device Functional Performance Characteristics 
for Gamma Knife 
 The deviation of the geometrical centre to the isocentre (unit 
centre point) must be specifi ed (in millimetres) for three orthogonal 
planes within the room coordinate system. 
 DIN 6875-1 – Treatment Planning System  
 The aim of these tests is to document the agreement between 
dose, dose distribution and geometrical localisation of the calcu-
lated and measured parameters  [7] . 
 (1) Data transfer from diagnostic imaging modalities to the 
treatment planning system including coordinate transformation 
and determination of known target points in stereotactic coordi-
nates. The distances between known and detected target points (in 
millimetres) have to be determined in three orthogonal planes. 
 (2) The maximal deviations and full width at half maximum 
values of calculated and measured isodose curves for at least three 
representative dose distributions have to be determined (in milli-
metres). 
 (3) The treatment planning system has to make available all 
necessary dosimetric data (e.g. D max , D min , D 50 , dose volume his-
togram) to document the stereotactic irradiation. 
 DIN 6875-1 – Imaging Accuracy 
 In general, distortions in diagnostic imaging modalities are an 
essential contribution to the total geometrical accuracy. Therefore, 
the imaging modalities used must be checked and prior to starting 
patient treatments the geometrical uncertainty of the imaging mo-
dalities must be known. This uncertainty (mean and max in mil-
limetres) must be checked routinely, especially after service and 
repair interruptions  [8–10] .  
 In order to check this, dedicated phantoms mounted to the ste-
reotactic frame and imaged with the same imaging protocols as for 
patients must be used. The marker positions within the phantom 
must be known within an uncertainty of  ! 0.2 mm. 
 DIN 6875-1 – System Test 
 This test quantifi es the overall accuracy of any stereotactic 
 treatment (SRS/SRT) by simulating a single isocentre irradiation 
( fi g. 7 ). In addition to other imaging modalities, the MR images are 
an integral part of the stereotactic system (SRS/SRT) and therefore 
must be tested. In order to evaluate how precisely a target can be 
irradiated, a marked GAFCHROMIC ®  fi lm is embedded between 
two PMMA plates both containing a capillary cross which can be 
fi lled with copper sulphate and coincides with the marked centre 
of the fi lm. The fi lm has additional marks at the edge so that dif-
ferent scans of the fi lm can be positioned automatically. The capil-
lary cross or fi lm plane together with the head phantom is adjusted 
either axially or sagittally within the stereotactic frame. The posi-
tion of the target is kept unknown until the dose is applied. After 
the MR/CT images have been imported, stereotactically defi ned 
and the dose planning has been performed, the phantom is irradi-
ated according to the data in the planning protocol. Finally, the fi lm 
coloured by the radiation is evaluated. The deviation from the cen-
tre of gravity of the coloured area to the central point marked at the 
beginning is measured  [1, 11] .  
 DIN 6875-1 – Verifi cation of Calculated Dose Calculations 
 Calculated dose distributions can be verifi ed by simulating the 
application of dose using the head phantom. After adjusting the 
coordinates and applying the dose, a stack of embedded fi lms is 
read and analysed  [12–15] . The resulting measured dose distribu-
tions can be compared to the calculated ones. 
 Results 
 Dosimetric Functional Performance Characterisitics 
for Gamma Knife 
  The output factors for the 4-, 8- and 14-mm collimator 
helmet relative to the 18-mm collimator helmet have been 
measured ( table 1 ) with different detectors which in prin-
ciple fulfi ll the requirements for narrow photon beam do-
simetry  [3, 4] . The detectors were placed with an uncer-
tainty of approximately 0.1 mm in the centre of a homo-
Table 1. Measured output factors (OF) using different dosimeters
Dosimeter 14 mm OF 8 1 SD 8 mm OF 8 1 SD 4 mm OF 8 1 SD
Pin point chamber
Liquid ionisation chamber
Diode
Diamond detector
LIF micro-cubes
TLD rods
Alanine dosimeter
GAFCHROMIC fi lm
Mean value
0.981580.0009
0.982980.0007
0.983480.0011
0.985480.0004
0.983980.0015
0.984280.0010
0.987080.0130
1.008080.0150
0.987080.00861
(0.928080.0020)
0.952380.0007
0.955080.0020
0.956980.0004
0.956180.0027
0.955880.0028
0.959080.0120
0.970080.0060
0.957880.00571
(0.663080.0060)
0.893080.0005
0.887480.0072
0.879780.0018
0.882680.0071
0.882180.0068
0.835080.0180
0.859280.0147
0.874180.02021
The fi gures in parentheses for the pin point chamber were not taken into account for calculating the mean 
values due to systematic errors [5].
1 Standard deviation of mean value. 
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geneous polystyrene sphere (diameter = 16 cm) which was 
mounted in the mechanical centre of the Gamma Knife. 
 For all collimator helmets, dose profi les with different 
detectors and radiochromic fi lms have been measured 
( fi g. 1 ) using the spherical head phantom. Similar results 
have been obtained comparing measured with calculated 
isodose curves in orthogonal planes using GAFCHRO-
MIC  fi lms. 
 Imaging Accuracy and Geometrical Functional 
Performance Characteristics 
 In order to check distortions in CT and MR images, a 
cylindrical phantom consisting of 145 rods, each 10 mm 
apart, was mounted in the stereotactic frame in such a 
way that the central rod coincided with a defi ned stereo-
tactic coordinate (x = 100 mm, y = 100 mm) in axial 
planes  [9] . The phantom was imaged with the same imag-
ing protocols used for patients ( fi g. 2 a, b).  
 The DICOM images are then postprocessed by a soft-
ware module (TOPAS) calculating the displacement vec-
tors for each rod, assuming a perfect geometrical match 
in the central position ( fi g. 3 ). Using stereotactic CT im-
ages, the mean radial deviation was found to be 0.1  8 
0.06 mm with a maximum deviation of 0.6 mm which is 
nearly independent of the distance from the central refer-
ence rod. However, in MR images, the mean radial de-
viation was up to 0.7  8 0.3 mm with a maximum of 
1.3–1.6 mm, depending on the imaging protocol used. 
Systematically increasing deviations were found with in-
creasing distance from the central reference rod.  
 By using the ‘known target phantom’ ( fi g. 4 ) with em-
bedded targets at known geometrical positions, either 45 
steel spheres for CT or 21 cross hairs for MR (each con-
sisting of 5 glass vials) following results could be obtained
( table 2 ). 
 With a similar phantom ( fi g. 5 ), image distortions in 
DSA images have been estimated to be up to 3.5 mm in 
the peripheral image regions due to the curved input 
phosphor of the image intensifi er ( fi g. 6 ).  
 Mechanical Isocentre (Unit Centre Point) Stability 
 The measured deviation of the radiological centre to 
the mechanical centre (unit centre point) of the Gamma 
Knife was measured in three orthogonal planes with a 
special tool representing the mechanical centre by a pin 
point marking a GAFCHROMIC fi lm. The deviation 
found for xy measurements was 0.20  8 0.13 mm. 
 System Test 
 The system test was performed using a spherical, tis-
sue-equivalent phantom with an MR visible cross at an 
unknown target position, to which a GAFCHROMIC 
fi lm was placed ( fi g. 7 ). After mounting this phantom into 
the stereotactic frame, stereotactic MR images were tak-
en. The shot position for a 4-mm collimator helmet was 
planned to coincide with the visible crossing point. By 
densitometric analyses of the fi lm after the irradiation, 
the deviation of the planned to the irradiated shot posi-
tion is determined. 
 Fig. 1. Calculated (broken lines) and mea-
sured (diamond detector, dots) relative 
Gamma Knife dose profi les along the y-axis 
for the 4-, 8-, 14- and 18-mm collimator hel-
met. 
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 Fig. 2.  a Cylinder phantom for determination of imaging 
distortions in MRI and CT. The phantom consists of 145 
rods which are arranged equidistantly in a quadratic
10-mm grid. The body is fi lled with distilled water.
 b Phantom within the fi ducial box ready for positioning 
in the head coil of the MR scanner. The phantom can
be adjusted in different directions so that either axial
or sagittal scans can be performed.  
 Fig. 3. Screenshot of the TOPAS main window after the 
calculations of the MR image distortions have been com-
pleted. The results are shown in the table (lower right 
corner) and are represented in colours according to their 
magnitude. 
2 
 3 
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 The results ( table 3 ) evaluating 170 system tests with-
in 5 years show that the mean displacement vector of the 
complete system is 0.48  8 0.23 mm (mean  8 SD). Fac-
tors having a signifi cant infl uence on the overall accuracy 
are associated with MRI parameters. Test results based 
on axial images (xy plane; 0.42  8 0.24 mm) are signifi -
cantly superior to coronal images (xz plane; x = 0.60  8 
0.02 mm). Furthermore, the 3-dimensional mpr sequence 
(0.40  8 0.19 mm) is signifi cantly superior to the T 1 -
weighted SE sequences (0.66  8 0.24 mm)  [1] . 
 Fig. 4. Known target phantom for stereotactic imaging.  a Slab phantom with 45 embedded steel spheres
(n 1 mm) for QA when using CT, angiography and DSA.  b Slab phantom with 21 embedded cross hairs (each 
cross hair consists of 5 glass vials with outer n 3 mm and inner n 2 mm) for verifi cation of geometrical localisa-
tion in MRI. 
 Fig. 5. Phantom for stereotactic DSA.  a Three-slab phantom with embedded steel sheres for QA of DSA.  b Rep-
resentation on the monitor showing the usual distortions (‘cushing effect’). 
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Table 2. Results (mm) from verifying 21 geometrically known targets in stereotactic space 
Marker Target coordinates Measured coordinates Absolute errors Distance
No. x y z x y z dx dy dz dr
1 100.0 70.0 45.0 100.1 70.1 45.2 0.1 0.1 0.2 0.24 62.6
2 75.0 100.0 45.0 75.2 100.2 45.2 0.2 0.2 0.2 0.35 60.4
3 150.0 40.0 60.0 150.0 40.0 60.1 0.0 0.0 0.1 0.10 87.7
4 125.0 70.0 60.0 125 70.0 60.1 0.0 0.0 0.1 0.10 55.9
5 100.0 100.0 60.0 100.0 100.0 60.1 0.0 0.0 0.1 0.10 40.0
6 75.0 130.0 60.0 75.1 130.1 60.1 0.1 0.1 0.1 0.17 55.9
7 50.0 160.0 60.0 50.1 160.0 60.1 0.1 0.0 0.1 0.14 87.7
8 100.0 130.0 75.0 100.0 130.1 75.0 0.0 0.1 0.0 0.10 39.1
9 50.0 40.0 90.0 50.0 40.0 90.0 0.0 0.0 0.0 0.00 78.7
10 150.0 100.0 90.0 150.1 100.0 90.0 0.1 0.0 0.0 0.10 51.0
11 125.0 130.0 90.0 125.1 130.1 90.0 0.1 0.1 0.0 0.14 40.3
12 25.0 70.0 105.0 25.0 70.1 105.0 0.0 0.1 0.0 0.10 80.9
13 175.0 130.0 120.0 175.0 130.1 120.0 0.0 0.1 0.0 0.10 83.2
14 150.0 160.0 120.0 150.0 160.0 120.0 0.0 0.0 0.0 0.00 80.6
15 100.0 40.0 135.0 100.1 40.1 134.9 0.1 0.1 0.1 0.17 69.5
16 75.0 70.0 135.0 75.0 70.1 134.9 0.0 0.1 0.1 0.14 52.4
17 50.0 100.0 135.0 50.0 100.0 134.9 0.0 0.0 0.1 0.10 61.0
18 25.0 130.0 135.0 25.0 130.1 134.9 0.0 0.1 0.1 0.14 88.0
19 175.0 70.0 150.0 175.0 70.2 149.8 0.0 0.2 0.2 0.28 95.0
20 125.0 100.0 150.0 125.1 100.2 149.8 0.1 0.2 0.2 0.30 55.9
21 100.0 160.0 150.0 100.1 160.1 149.8 0.1 0.1 0.2 0.24 78.1
The right column delivers the distance to the position 100/100/100 (Leksell coordinate system).
 Fig. 6. Results of QA measurements for a DSA (Philips Integris Allura) using the 3-slab phantom.  a The devia-
tions of the spheres to the real given positions as a function of distance to the centre.  b After applying a correction 
algorithm, all markers appear within 0.6 mm to the real given position in the phantom. 
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 Fig. 8. Verifi cation of a calculated 3-dimensional dose distribution 
for an acoustic neurinoma: the GAFCHROMIC  fi lms are embed-
ded between the slabs and inserted into the phantom ( a ) which is 
adjusted according to the data in the protocol. The acoustic neuri-
noma was planned ( b ) and the fi lms are analysed. The screenshot 
shows dose distributions on the basis of absolute dose measure-
ments ( c ) and the representation of the corresponding 3-dimen-
sional dose plot ( d ). 
 Fig. 7. Global system test  [20] for radiosurgery ‘cross test’: a GAFCHROMIC 
fi lm with a premarked double cross embedded between the two capillary cross 
inserts runs through all limbs of the treatment chain inside the head phantom 
beginning with the imaging, defi nition and localisation of the target to the plan-
ning and the fi nal adjustment of the coordinates according to the values in the 
protocol. The deviation of the coloured spot on the fi lm to the middle of the marked double cross is evaluated. In addition to that, the 
imaging devices (CT, MRI) could also be checked against a reference image (X-ray anterior posterior/lateral direction).
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 Verifi cation of Calculated Dose Distributions 
 A stack of embedded fi lms ( fi g. 8 a) is analysed. The 
resulting measured dose distributions ( fi g. 8 c, d) can be 
compared to the calculated ones ( fi g. 8 b)  [12, 13] . Sev-
eral slab thicknesses can be chosen. The fi lm thickness of 
0.3 mm is the limiting parameter of the resolution or-
thogonal to the fi lm plane. Several spacer plates (1.5, 3.0 
and 6 mm) allow any composition of stacks. Furthermore, 
different materials and detectors can be combined. 
 Conclusion 
 Given the high mechanical accuracy and long-term 
stability of the Leksell Gamma Knife, which is 0.20  8 
0.13 mm, the most sensitive technical factor having an 
infl uence on the overall precision of radiosurgery is the 
MRI. Besides QA phantoms and analysis software devel-
oped in-house, which also fulfi ll the demands of the DIN 
standard, the use of commercially available tools, manu-
factured and distributed by the PTGR GmbH, Tübingen, 
Germany, facilitates the QA according to the DIN 6875-
1 and signifi cantly speeds up the analysis. 
 
Table 3. Results of 170 consecutive system tests, based on MR tar-
get point localisation 
a   Acquisition plan
Deviation All Axial Coronal
Mean, mm 0.48 0.42 0.60
Sigma, mm 0.23 0.24 0.15
n 170 116 54
Min, mm 0.10 0.10 0.32
Max, mm 1.12 1.12 0.92
Median, mm 0.44 0.32 0.63
b   MRI sequence
Deviation All SE 3-dimensional 
mprage
Mean, mm 0.48 0.66 0.40
Sigma, mm 0.23 0.24 0.19
n 170 50 120
Min, mm 0.10 0.14 0.10
Max, mm 1.12 1.12 0.73
Median, mm 0.44 0.71 0.36
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